Belong news: New Melanoma Med group managed by Prof. Michal Lotem has been launched!
Prof. Lotem is the head of the Melanoma and Immunotherapy Unit at the Sharet Oncology Dep. at the HMC and an international expert in skin cancer, clinical oncology and radiotherapy.
Prof. Lotem was involved in research, with Dr. Steven Rosenberg, founder and leader of Cancer Immunotherapy at NCI of the NHI, in Maryland. His unique treatment “adoptive cell therapy” is implemented at HMC in co-operation with the bone marrow transplant unit.
We thank Prof. Michal Lotem for her support and willingness to manage dialogues and conversations with patients and provide Belong members with answers in her fields of expertise.
We continue to work hard to provide the Belong community with world leading experts, top notch medical professionals, increase in crucial information availability and shorter professional response time, all in order to help you manage the fight against cancer more efficiently while improving your quality of life.
Wishing you the best of health,
The Belong team